Modeling Reveals How Direct-Acting Antivirals Redirect HBV Capsid Assembly Pathways to Noninfectious ProductsLayne Braedon Frechette, Michael F. Hagan, Farzaneh Mohajerani et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0